OTLC Buy Disclosure
Trieu Vuong · SEC Form 4 · Filed Oct 30, 2026
Buy
Calculated transaction value
$17.76K
Trieu Vuong Chairman And CEO
OTLC
Transaction date
Oct 29, 2026
Public filing date
Oct 30, 2026
Filing lag
Filed 1 day later
OTLC daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,044,990 shares @ $0.02
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001493152-26-049370
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$23.54K
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oncotelic Therapeutics, Inc. OTLC Current | Buy | Oct 29, 2026 | $17.76K |
| Oncotelic Therapeutics, Inc. OTLC | Buy | Oct 28, 2026 | $5.77K |